Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris aps - acetylsalicylsyre - tabletter - 75 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - acetylsalicylsyre - enterotabletter - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - acetylsalicylsyre - tabletter - 500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - acetylsalicylsyre - filmovertrukne tabletter - 150 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - quetiapin fumarat - filmovertrukne tabletter - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - quetiapin fumarat - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - quetiapin fumarat - filmovertrukne tabletter - 25 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - quetiapin fumarat - filmovertrukne tabletter - 300 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

tetris pharma b.v - glucagon - diabetes mellitus - pancreas hormoner, hormoner glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).